These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2759343)

  • 1. Symposium on Continuous Cell Lines as Substrates for Biologicals. Arlington, Virginia, USA (Washington, D.C.), May 26-29, 1988. Proceedings.
    Dev Biol Stand; 1989; 70():1-304. PubMed ID: 2759343
    [No Abstract]   [Full Text] [Related]  

  • 2. Status of WHO concerning continuous cell lines as substrates for the production of biologicals.
    Grachev V; Magrath D
    Dev Biol Stand; 1989; 70():215-9. PubMed ID: 2759349
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings of the Joint ESACT -- IABS meeting on the use of heteroploid and other cell substrates for the production of biologicals. Heidelberg (F.R. Germany) 18-22 May, 1981.
    Dev Biol Stand; 1981; 50():1-398. PubMed ID: 7341286
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous cell lines as substrates for biologicals. Draft position paper. Pharmaceutical Manufacturer's Association.
    Dev Biol Stand; 1989; 70():285-7. PubMed ID: 2759355
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings of the 1st International Symposium on Risk Assessment for Veterinary Biologicals: The Next Step in International Harmonisation. Arlington, Virginia, 5-7 December 1994.
    Rev Sci Tech; 1995 Dec; 14(4):903-1220. PubMed ID: 8639959
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals.
    World Health Organ Tech Rep Ser; 1987; 747():1-29. PubMed ID: 3107222
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances No 50).
    Dev Biol Stand; 1998; 93():141-71. PubMed ID: 9737395
    [No Abstract]   [Full Text] [Related]  

  • 9. Theoretical considerations and practical concerns regarding the use of continuous cell lines in the production of biologics.
    Petricciani JC; Salk PL; Salk J; Noguchi PD
    Dev Biol Stand; 1981; 50():15-25. PubMed ID: 7341291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety issues relating to the use of mammalian cells as hosts.
    Petricciani JC
    Dev Biol Stand; 1985; 59():149-53. PubMed ID: 3891461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production.
    Griffiths E
    Dev Biol Stand; 1999; 98():153-7; discussion 167. PubMed ID: 10494968
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumorigenicity testing of various cell substrates for production of biologicals.
    Furesz J; Fanok A; Contreras G; Becker B
    Dev Biol Stand; 1989; 70():233-43. PubMed ID: 2759351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insect cells as substrates for biologicals.
    Weiss SA; Belisle BW; DeGiovanni A; Godwin G; Kohler J; Summers MD
    Dev Biol Stand; 1989; 70():271-9. PubMed ID: 2759354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous cell lines as substrates for biologicals: report of a joint meeting of WHO, IABS (cell Culture Committee Subsection), and ESACT.
    Spier RE
    Mol Biother; 1988; 1(2):114-5. PubMed ID: 3269249
    [No Abstract]   [Full Text] [Related]  

  • 15. Large scale animal cell cultivation for production of cellular biologicals.
    van Wezel AL; van der Velden-de Groot CA; de Haan HH; van den Heuvel N; Schasfoort R
    Dev Biol Stand; 1985; 60():229-36. PubMed ID: 3899783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A collaborative study on DNA quantitation in biological products.
    Robertson JS; Heath AB
    Biologicals; 1995 Sep; 23(3):199-205. PubMed ID: 8527118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current experience with biological products produced in various continuous cell lines. Summary and conclusions.
    Papermaster BW
    Dev Biol Stand; 1989; 70():227-9. PubMed ID: 2759350
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings of the Symposium on Target Organ Toxicity: Eye, Ear and other Special Senses. February 2-3, 1981. Arlington, Virginia.
    Environ Health Perspect; 1982 Apr; 44():1-195. PubMed ID: 7084143
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic stability and product consistency of rDNA-derived biologicals from mammalian cells.
    Bebbington CR; Lambert K
    Dev Biol Stand; 1994; 83():183-4. PubMed ID: 7883094
    [No Abstract]   [Full Text] [Related]  

  • 20. Industry perspective for biotech products.
    Möritz A
    Dev Biol (Basel); 2004; 118():37-44. PubMed ID: 15645671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.